Bachem Increases Sales and Profitability @BachemGroup #Biotechnology #Chemical #HealthCare #Medical #Pharmaceuticals #OTC #OTCMarkets #OTCStocks #Investing
Ad hoc announcement pursuant to Art. 53 LR Media Release Bachem increases sales and profitability Group sales rise to CHF 605.3 million (+4.8%) in 2024. EBITDA increases to CHF 176.3 million (+5.7%). EBITDA margin lies at 29.1%. In local currencies sales rise by 5.6% and EBITDA increases by 7.7% to a margin of 29.4%. ...
http://dlvr.it/TJCpjh
http://dlvr.it/TJCpjh
Comments
Post a Comment